Increasing engagement with online programs to improve mental health in the community: The Engagement Project

Australian National University

Dataset description

This 3-arm randomized controlled trial (N=849, 76.1% female, aged 18-66+) assessed the independent efficacy of the engagement facilitation interventions and myCompass 2 program. The myCompass 2 program was delivered with or without the engagement facilitation interventions; both conditions were compared with an attention control condition. Data includes demographic information and psychopathology (anxiety, depression, Quality of Life, and suicidality).
Click to explore relationships graph

Source Study

Trial acronym

Enhancing Engagement with Psychosocial Interventions (EEPI)

Trial ID





Not Applicable


Government body,National Health and Medical Research Council (NHMRC)

Scientific enquiries

Dr Amelia Gulliver

Brief Summary

This study will test using a randomised controlled trial a brief online intervention (an Acceptance-Facilitation Intervention, AFI) designed to increase uptake and adherence to an online mental health program (myCompass 2). The primary hypotheses are that uptake of the program will be higher in the AFI + myCompass 2 condition relative to the myCompass 2 alone condition (H1), and that more participants will adhere to the intervention in the AFI + myCompass 2 condition relative to myCompass 2 alon ....
Read more

Key Inclusion Criteria

1) Symptoms of depression OR anxiety in the mild to moderate range (PHQ-9 OR GAD-7 score at screening of 5-14). 2) Aged 18 years or over and living in Australia.

Key Exclusion Criteria

1) Previous use of the myCompass online program. 2) Receiving psychological therapy at screening. 3) Had a suicide plan in the past month. 4) Diagnosis of psychosis or bipolar disorder. 5) Symptoms of depression AND anxiety in the none/low range (PHQ-9 AND GAD-7 score at screening of 0-4). 6) Symptoms of depression OR anxiety in the severe range (PHQ-9 OR GAD-7 score at screening of 15+).

Can healthy volunteers participate?




Sample Size    849

Min. age    18 Years

Max. age    No limit

Sex    Both males and females

Condition category    Anxiety , Depression

Condition code    Mental Health


Intervention code Treatment: Other

Arm 1 - AFI + myCompass 2 Arm 2 - myCompass 2 alone AFI: The Acceptance-Facilitation Intervention (AFI) will consist of brief (approximately 5 minutes), tailored material presented online to the participant after they are randomised to a condition but before they start the myCompass 2 intervention. The material will be designed to challenge many of the personal barriers to engagement with psychosocial interventions, informed by theory emphasising the importance of social norms in the acceptabili ....
Read more


Control group Active

The attention control condition will consist of 14 brief modules of public domain health and lifestyle information, matched for time taken to complete the myCompass 2 program. After participants have completed their follow-up surveys they will be invited to use the myCompass 2 program.


Outcome: Uptake as assessed by - number of individuals who access at least one therapeutic module of the program.
Timepoint: 7 weeks post-randomisation

Outcome: Adherence as assessed by number of modules completed of myCompass 2
Timepoint: 7 weeks post-randomisation

Will individual participant data (IPD) for this trial be available?


What data in particular will be shared?

Deidentified participant data supporting the publication results and primary outcomes

When will data be available?

Data are available for an indefinite time Start date: July 2023 (approx) End date: Unknown

Available to whom?

Data are potentially available to researchers from not-for-profit organisations based in any location. All data requests will be considered by the primary sponsor on a case-by-case basis. Requests must include a methodologically sound proposal. Specific conditions of use may apply and will be specified in a data sharing agreement (or similar) that the requester must agree to before access is granted. For further information, see

Available for what types of analyses?

Assessed on a case-by-case basis

Source study information is derived from the Australian New Zealand Clinical Trials Registry (ANZCTR). For more information on the ANZCTR, please see